ClinInvent partners with Afferenz
Our News Bureau – Mumbai
Afferenz, a strategic business unit of Megasoft, which addresses the data and information management needs of lifesciences companies, announced a strategic partnership with ClinInvent Research.
They will jointly address the market needs for clinical trial data management services and biostatistics. Afferenz’s portfolio of software based clinical trials solutions together with the data management practices of ClinInvent Research promises to bring in a comprehensive offering to customers in the area of data management services.
“With the increasing growth of outsourced clinical trials from overseas into India, this partnership will eliminate the customers’ problems of co-ordinating with multiple entities from a distance,” said Kallol Biswas, Vice-President, Afferenz. “ClinInvent’s knowledge and experience in clinical trials data management services together with our integrated clinical trials solution, Acceliant will offer a complete solution from a single point to our customers, especially those in the US where we have a large footprint,” he adds. Afferenz’s Acceliant eClinical Suite is a comprehensive solution that offers users real-time efficiency, ease of use in trial design, flexibility, regulatory compliance, and the unique ability to integrate multi-modal electronic data capture (EDC), data management, trial management, online image analysis and document management with traditional paper-based processes.
ClinInvent, a part of TCG Lifesciences, is a full fledged contract research organisation, which provides comprehensive clinical services in clinical trial management, data management, bio-statistics, medical writing, pharmacovigilance, quality assurance and GCP training. “ClinInvent’s data management expertise is enhanced by the addition of Acceliant. And the strategic partnership with Afferenz provides us with an opportunity to move fast into global EDC arena,” said Dr Arun Bhatt, President, ClinInvent.